CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,545 enrolled
Drug / intervention
IFA vs. MMS during pregnancydietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05867836
NCT05867836N/ACompleted

Trial of Adherence and Acceptance of Multiple Micronutrient Supplementation (MMS) vs Iron and Folic Acid (IFA) Among Pregnant Women and Health System Enablers and Constraints Related to MMS in Cambodia

University of British Columbia·interventional·Posted May 22, 2023·Updated Sep 23, 2024

In Brief

A clinical study evaluating IFA vs. MMS during pregnancy for Pregnancy Related and 2 related conditions. Completed, enrolled 1,545 participants across 1 site.

Detailed Summary

Iron and folic acid (IFA) supplements are currently provided to Cambodian women during pregnancy. However, recent research has showed benefit of a multiple micronutrient supplement (MMS) over just IFA alone on several outcomes of perinatal and infant health. The Ministry of Health in Cambodia has proposed a transition from IFA to MMS but would like to collect some formative research on this first to assess acceptability and adherence to MMS (over IFA) and help guide key messaging, packaging, and practices to guide the transition in Cambodia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCambodia

Timeline

N/ACompletedFinished
202420252026
First PostedMay 22, 2023
Enrollment StartMar 1, 2023
Primary CompletionJun 1, 2024
Study CompletionSep 1, 2024
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 3.1 years ago

Interventions

IFA vs. MMS during pregnancydietary

Iron and folic acid, or multiple micronutrient supplements provided during pregnancy